Tag : Thyroid

Cardiology

The association of thyroid stimulation hormone levels with incident ischemic heart disease, incident stroke, and all-cause mortality.

Newsemia
Related Articles The association of thyroid stimulation hormone levels with incident ischemic heart disease, incident stroke, and all-cause mortality. Endocrine. 2020 Feb 10;: Authors: Møllehave...
Latest News

The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation

Newsemia
Barbera, JPM; Clements, M; Thomas, P; Rodriguez, T; Meloy, D; Kioussis, D; Beddington, RSP; (2000) The homeobox gene Hex is required in definitive endodermal tissues...
Gastroenterology

World Trade Center rescue and recovery workers found to have increased leukemia incidence

Newsemia
Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the...
Surgery/Cosmetic

The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis

Newsemia
Our systematic review of the literature aimed to confirm the controversial association between preoperative TSH levels and the risk of DTC in patients who present...
Gastroenterology

Mount Sinai physicians emphasize the importance of early detection, treatment of thyroid disease

Newsemia
January is Thyroid Awareness Month, and physicians from the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease and the Department of...
Latest News

Global Thyroid Cancer Drugs Market Report 2020: Focus on Ipilimumab, Cabozantinib-S-Malate, Caprelsa, Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The “Thyroid Cancer Drugs Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global thyroid cancer drugs market was valued at...
Latest News

Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer

Newsemia
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy